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Aims: Toll l ike receptors (TLRs) have been implicated in defense against microbial 
infections. Indeed, animal models have demonstrated that susceptibility o a number 
of gram negative pathogens i  l inked to TLR4 and thus lipopoly saccharides (LPS) 
of many gram negative bacteria have been implicated as virulence factors in a 
number of diseases. The aim was to assess the role of this pathogen associated 
molecular pattern as it is exposed on intact Pseudomotw~s aerug#u~sa, 
Methods. The susceptibility of mice lacking TLR4 or both TLR2 and 4 was 
examined in a model of acute Pseudomonas pneumonia. 
Results: The mutant mice were not hypersusceptible to the Pseudomonas challenge 
and mounted an effective inf lammatory esponse that cleared the organism, despite 
low levels of TNF alpha and KC ha the airways. Microorganism and neutrophil 
counts were similar in control and deficient TLR mice at 6 and 24 hours after 
infection. MyD884 mice were however hypersusceptible with 100% of micedy ing 
within 48 hours with a lower dose of/~ aeruginosa. Of note there was normal evels 
of interleukin 6 (IL 6) and granulocyte colony stimulating factor (G CSF) in the 
airways of the TLR mutant mice that was absent from the MyD88 deficient mice. 
Conclusion: The susceptibility of mice to/~ aeruginosa cute lung infection does 
not go tbrough TLR2 or TLR4, negating Pseudomonas LPS as an important 
virulence factor ha acute lung disease caused by this organism. Furthermore the 
resistance to infection in these mice may be l inked to IL 6 and G CSF production. 
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Elevated levels o fMMP 9 have been identified ha Cystic Fibrosis (CF). Respiratory 
epithel ium constitutively expresses MMP 9, which can be upregulated by ilRlam 
matory stimuli such as TNF alpha. MMP 9 is hlhibited by TIMP 1. Glutathione 
(GSH) is a major intracellular antioxidant that can modulate the ilRlammatory 
response. We hypothesized that augmentation of intracellular glutathione by GSH 
supplementation would diminish MMP 9 production. 
Aim: To quantify respiratory epithelial cell MMP 9 and T IMP 1 production, basally 
and ha response to stimulation with TNF alpha (10 ng/mL), with and without GSH 
augmentation. 
Methods: Airway epithelial cell lines expressing either wildtype (9HTEo)  or 
deltaF508 (CFFE29o)  CFFR. 
Zymography: MMP 9 and Timp 1 activity were quantified by zymography and 
reverse zymogr aphy, respectively. 
Results: There was a significant increase ha MMP 9 production post TNF alpha 
stimulation ha both cell lines, with no significant change in TIMP 1 levels. 
Supplementation with GSH did not significantly change basal MMP 9 or T IMP 1 
production. However stimulation with TNF alpha in the presence of GSH 
supplementation demonstrated a significant reduction in MMP 9 production 
(P<0.05) with a significant increase in TIMP 1 production (P<0.05) ha the CF cells. 
A similar, but non significant, rend was identified ha the wildtype cell line. 
Conclusion: Glutathione augmentation resulted in both a decrease ha MMP 9 
production and an increase ha TIMP 1 production by respiratory epithelial cells ha 
response to stimulation by TNF alpha. These changes could l imit the parenchymal 
damage in CF. This is one other mechanism whereby therapies aimed at increasing 
intracellular GSH may be beneficial in CF. 
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Activation of Toll l ike receptors (TLRs) on airway epithelial cells has been shown 
to be involved ha the regulation of a variety of genes including those encoding 
cyt okhaes. Toll receptors constitute the first l ine of defence against many pathogens. 
The aims of this study were to analyse TLR 2 & TLR4 expression on epithelial and 
macrophage cells in response to B.cenocepacia BC7 & B .multivorans LMG10310 
infection. A549 epithelial cells mad U937 macr ophage l ike cells were seeded into 6 
wel l  plates prior to infection with either BCC strain or 10 ng/ml LPS for 4 & 24 brs. 
Cell surface and intracellular TLR2 & TLR4 expression were analysed by f low 
cytometry. The results demonstrate hat A549 epithelial cells constitutively express 
low levels of surface TLR 2 & 4 and do not increase ha response to BCC strains or 
LPS. In contrast, intracellular levels of TLR4 were 10 fold higher than surface 
TLR4 levels. Cells infected with B.cenceepacia BC7 significantly down regulated 
intracellular TLR4 expression (P<0.026) after 24 brs infection. Infection with 
B.multivorans LMG10310 or LPS also induces a down regulation of intracellular 
TLR4 expression, but this is not significant. U937 cells also show a down regulation 
of TLR2 and TLR4 expression after BCC or LPS stimulation. BCC strains are 
known to invade A549 epithelial cells and induce a prohfflammatory cytokine 
response suggesting that upon infection of the cells, signall ing through intr acellular 
TLR4 may be a contributing factor in the prohfflammatory response that ensues. 
Future work wi l l  involve examining mRNA expression of TLR2 & 4 and 
intr acellular signall ing cascades involved ha epithelial and macr ophage responses to 
BCC infection. 
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The mechanisms by which defective CFTR protein produces airway disease are not 
fully elucidated. However, a growing consensus indicates hat the CF airways are 
marked by an aberrant and dysregulated infiammatory response. In the present 
study the possibi l i ty that mutated CFTR protein may itself  ampli fy the 
ilfflammatory responses to bacterial pathogens has been evaluated ha C127 (mouse 
epithelial cells CFTR wit or AF508) and IB3 (human bronchial cells CFTR 
AF508/W1282X,) cell lines. C127 cells were infected with a laboratory strain of 
Pseudomonas aeruginosa (PAO1) (0.05 5 cfu/cell) and ICAM 1 mRNA was 
quantitated 4 hours after infection by real t ime PCR. PAO1 infection increases 
ICAM 1 transcription ha a dose dependent manner. ICAM 1 mRNA induction is 
significantly higher in C127 CFTR AF508 than ha CFTR wit  cells (P<0.04). A 
sharply increased response of C127 AF508 cells appears within 2 hours post 
infection, and this does not correlate with augmented bacterial binding to the cells, 
as tested with metabolically labelled PsS]PAO1. IB3 and $9 cells (IB3 l ine 
corrected with CFFR w/t) were infected with PAO1 as indicated mad mRNA levels 
of ICAM 1 and IL  8 were determined. Infection with PAO1 up regulates both 
ICAM 1 and IL  8 transcripts. Induction of ICAM 1 mRNA, IL  8 mRNA mad IL 8 
protein are significantly higher in IB3 than ha$9 cells (P<0.03, P<0.CO7, P<0.008). 
These results indicate that the expression of mutated CFTR is associated with 
augmented i lRlammat ory responses upon infection by PA. 
Supported by the Ital ian fi~ystic Fibrosis Research Foundation (FFC#14/2CO4) mad 
Legge 548/93, Finanziamento Ricerca Fibrosi Cistica 2CO4. 
